Europe

  • VitalHub UK and CEMBooks announce partnership

    VitalHub UK and CEMBooks have announced a partnership focused on supporting NHS organisations with complementary digital tools for operational insight and situational awareness. The partnership brings together SHREWD, VitalHub UK’s system-level operational platform used to support escalation, coordination, reporting and digital OPEL, with CEMBooks’ department-focused operational management tools. The aligned solutions uniquely enable organisations to [...]

  • Electiva launches Patient Charter in major safety and transparency drive across UK elective healthcare

    Electiva Healthcare Group has unveiled a new Patient Charter and strengthened clinical governance framework in a significant move to raise safety, transparency and accountability standards across its expanding UK network. The announcement comes amid growing national focus on clinical governance, as healthcare providers face increasing scrutiny to ensure patient safety and quality keep pace with [...]

  • Highland launches Elevate – bringing health tech direct to the NHS

    A new showcase series is reshaping NHS-supplier engagement. Pioneers at the first NHS host brought together hundreds of staff organisation-wide, along with major tech companies and niche innovators in a single day, already inspiring 10 further NHS providers to follow in 2026. Highland has launched Elevate, a new health tech event series that is bringing [...]

  • LUMO Labs fund secures €6m from Spain

    LUMO Labs’ LUMO Fund has secured €6m from Spain’s state-backed investment arm SETT to support early-stage startups across Spain and Europe. The €100m LUMO Fund is a multi-stage venture capital fund covering pre-seed to Series A investments. It plans to invest in around 30 to 35 startups over the next four years. The fund also [...]

  • Qura raises €1.5m for AI health platform

    AI health platform Qura has raised €1.5m in pre-seed funding to support its plans to improve how non-emergency health conditions are managed across Europe. The funding will be used to expand hiring across medical, engineering and operations teams, invest in digital marketing and community-led growth, advance Qura’s AI health intelligence capabilities and prepare for expansion [...]

  • MyWay Digital Health secures £3m to scale NHS diabetes tool

    MyWay Digital Health has secured £3m in funding to scale its diabetes management platform, which is used across several NHS regions. The Edinburgh-based company, spun out of the University of Dundee in 2017, employs 30 staff across Dundee, Edinburgh and London. It develops data-driven technology to support the management of long-term conditions, with a particular [...]

  • Access to National Healthcare Systems: The deadline for action is getting closer

    NHS England has introduced a new depreciation timeline for CIS1, requiring trusts to move completely to CIS2 by 28 February 2027, when access to CIS1 will be removed. Andrew Harrison, director, product management - international at Imprivata, discusses the drive for more secure access to electronic patient record systems that is affecting hospitals in the [...]

  • Alcidion delivering ‘Software as a Medical Device’ AI capabilities in both Australia and the UK

    Alcidion today announces that Miya Precision Concept Detection has been included on the Australian Register of Therapeutic Goods (ARTG – #522634) as a Class 1 Medical Device. The capability has also been successfully registered as a Class 1 Medical Device with the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom. Concept Detection [...]

  • Gene therapy’s inflexion point: From scientific breakthrough to systemic transformation

    By Sanius Health Gene therapy has now moved decisively from scientific ambition to clinical reality, and in doing so, it has redefined what is possible for patients living with severe genetic conditions such as sickle cell disease, where curative intent is no longer a distant aspiration but a regulated, deployable therapeutic pathway. What we are [...]

  • McDermott advises Fidia Farmaceutici on the acquisition of Altacor Ltd

    McDermott Will & Schulte advised Fidia Farmaceutici S.p.A. on its acquisition of Altacor Ltd, a UK‑based ophthalmic products company. The transaction marks a significant strategic step for Fidia as it enters the UK ophthalmology market directly, enhancing its presence in one of the group’s core therapeutic areas. Through the acquisition, Fidia expands its portfolio with [...]